Real World Glycemic Effectiveness of Linagliptin Among Type 2 Diabetes Mellitus Adults by Age and Renal Function
Phase of Trial: Phase IV
Latest Information Update: 08 May 2019
Price : $35 *
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 31 Aug 2018 Biomarkers information updated
- 09 Feb 2018 Status changed from active, no longer recruiting to completed.
- 19 Jan 2018 Status changed from not yet recruiting to active, no longer recruiting.